Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/21645515.2020.1787067 http://scihub22266oqcxt.onion/10.1080/21645515.2020.1787067 32703069!7733917!32703069     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hum+Vaccin+Immunother 2020 ; 16 (11): 2604-2608 Nephropedia Template TP {{tp|p=32703069|t=2020. Promise and challenges in the development of COVID-19 vaccines |pdf=|usr=}}{{32703069}} gab.com Text Promise and challenges in the development of COVID-19 vaccines JO: Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=32703069 #FOAvip The pandemic outbreak of COVID-19, caused by coronavirus SARS-CoV-2, created an unprecedented challenge to global public health system and biomedical community. Vaccination is an effective way to prevent viral infection, stop its transmission, and develop herd immunity. Rapid progress and advances have been made to date in the development of COVID-19 vaccines. Currently, more than 115 vaccine candidates have been developed from different technology platforms with several of them in clinical trials. Most of those vaccine candidates are developed based on the experience with other coronaviruses with an aim to induce neutralizing antibodies against the viral spike protein or its different receptor binding domains. Here, we discuss the promise, potential scientific challenges, and future directions for the development of a safe and effective COVID-19 vaccine. We also emphasize the importance of a better understanding of the infection pathogenesis and host defense mechanisms against SARS-CoV-2 infection. Twit Text FOAVip Promise and challenges in the development of COVID-19 vaccines ????Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=32703069 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32703069 #FOAvip English Wikipedia <ref>{{Cite pmid|32703069}}</ref> Promise and challenges in the development of COVID-19 vaccines #MMPMID32703069 Chen W Hum Vaccin Immunother 2020[Nov]; 16 (11): 2604-2608 PMID32703069show ga The pandemic outbreak of COVID-19, caused by coronavirus SARS-CoV-2, created an unprecedented challenge to global public health system and biomedical community. Vaccination is an effective way to prevent viral infection, stop its transmission, and develop herd immunity. Rapid progress and advances have been made to date in the development of COVID-19 vaccines. Currently, more than 115 vaccine candidates have been developed from different technology platforms with several of them in clinical trials. Most of those vaccine candidates are developed based on the experience with other coronaviruses with an aim to induce neutralizing antibodies against the viral spike protein or its different receptor binding domains. Here, we discuss the promise, potential scientific challenges, and future directions for the development of a safe and effective COVID-19 vaccine. We also emphasize the importance of a better understanding of the infection pathogenesis and host defense mechanisms against SARS-CoV-2 infection. |Antibody-Dependent Enhancement/immunology[MESH] |COVID-19 Vaccines/*immunology[MESH] |COVID-19/pathology/*prevention & control[MESH] |Humans[MESH] |Immunity, Herd[MESH] |SARS-CoV-2/*immunology[MESH] |Spike Glycoprotein, Coronavirus/*immunology[MESH] |Vaccination[MESH]Promise and challenges in the development of COVID-19 vaccines (epmc).pdf DeepDyve Pubget Overpricing